| Clinical outcomes during follow-up | |||||
---|---|---|---|---|---|---|
ESRD | Myocardial infarction | Stroke | ||||
No | Yes | No | Yes | No | Yes | |
LEA at baseline | ||||||
 No | 644 (93.1 %) | 48 (6.9 %) | 697 (95.5 %) | 33 (4.5 %) | 698 (97.1 %) | 21 (2.9 %) |
 Yes | 44 (86.3 %) | 7 (13.7 %) | 43 (72.9 %) | 16 (27.1 %) | 51 (91.1) | 5 (8.9 %) |
HR (95 % CI) model 1 | 2.69 (1.17–6.20) |  | 3.53 (1.79–6.97) |  | 1.76 (0.60–5.14) |  |
P | 0.02 | Â | 0.0001 | Â | 0.29 | Â |
HR (95 % CI) model 2 | 2.49 (1.02–6.06) |  | 3.21 (1.50– 6.85) |  | 1.28 (0.37–4.43) |  |
P | 0.04 | Â | 0.003 | Â | 0.69 | Â |
SHR (95 % CI) model 3 | 2.41 (1.04–5.87) |  | 3.16 (1.53–6.52) |  | 1.49 (0.46–4.84) |  |
P | 0.04 | Â | 0.002 | Â | 0.50 | Â |